Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

08 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/redhill-launches-enforcement-of-11-million-new-york-supreme-court-final-judgment-against-kukbo-302793864.html

03 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/redhill-biopharma-advancing-opaganib-options-for-ebola-virus-disease-outbreak-302790437.html

02 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/redhill-biopharma-advancing-opaganib-options-for-novel-dual-host-directed-and-direct-acting-antiviral-approach-for-ebola-outbreak-biodefense-platforms-302788468.html

30 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/redhills-rhb-204-demonstrates-comparable-map-killing-efficacy-to-rhb-104---important-step-in-rhb-204-development-for-map-related-crohns-disease-302758691.html

27 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/redhill-biopharma-announces-full-year-2025-financial-results-and-operational-highlights-302754141.html

22 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/redhills-opaganib-enhances-efficacy-of-neuroblastoma-chemo-combination-and-augment-anti-tumor-immunity-in-triple-negative-breast-cancer-in-preclinical-studies--new-data-presented-at-aacr-2026-302750239.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE